DexCom, Inc., a medical device company, focuses on the design, development, and
commercialization of continuous glucose monitoring (CGM) systems in the United
States and internationally. The company provides its systems for use by people
with diabetes, as well as for use by healthcare providers. Its products include
DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time
API, which enables invited third-party developers to integrate real-time CGM
data into their digital health applications and devices; Dexcom ONE, that is
designed to replace finger stick blood glucose testing for diabetes treatment
decisions; and Dexcom Share, a remote monitoring system. The company's products
candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc.
has a collaboration and license agreement with Verily Life Sciences LLC and
Verily Ireland Limited to develop blood-based or interstitial glucose
monitoring products. The company markets its products directly to
endocrinologists, physicians, and diabetes educators. DexCom, Inc. was
incorporated in 1999 and is headquartered in San Diego, California.
